Showing 1851-1860 of 9945 results for "".
PR Is the Next Big Thing for Online Dermatology Marketing
https://practicaldermatology.com/topics/practice-management/pr-is-the-next-big-thing-for-online-dermatology-marketing/22954/Dermatology marketers should evaluate current SEO to make room for public relations strategies.Medical Meets Cosmetic in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/medical-meets-cosmetic-in-dermatology/21550/The contrast between cosmetic and medical may appear sharp, but a sound approach to dermatology requires both balance and blend.Filler Pearls: Refining the Art of Injection
https://practicaldermatology.com/topics/general-topics/filler-pearls-refining-the-art-of-injection/21683/Pain control is essential to treatment success with dermal fillers. Here's an update on pain management and other tactics to ensure patient comfort and optimize outcomes.Exploring the Role for a New Photodynamic Cosmetic Treatment
https://practicaldermatology.com/topics/general-topics/exploring-the-role-for-a-new-photodynamic-cosmetic-treatment/21756/A new procedure may bridge the gap between superficial chemical peels and laser therapy.Lip Lifts: A Procedure to Consider
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/lip-lifts-a-procedure-to-consider/23033/Consider referring for a surgical lip lift when fillers don’t suffice.Journal Club: Comparing Recommendations from Different AD Guidelines
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-comparing-recommendations-from-different-ad-guidelines/24466/Peter Lio, MD, talks with Robert Sidbury, MD, MPH, a pediatric dermatologist at Seattle Children's Hospital, about some of the differences in recommendations from the Annals of Allergy, Asthma, and Immunology Joint Task Force AD guidelines, and the Journal of the American Academy of Dermatology (JAAFirst Cell-Based Gene Therapy for RDEB
https://practicaldermatology.com/series/dermwire-tv/first-cell-based-gene-therapy-for-rdeb/35742/In this week's DermwireTV, the FDA approves the first cell-based gene therapy for recessive dystophic epidermolysis bullosa (RDEB); a new acne scar treatment using focal point technology is cleared in the US; and in our “Updates on Skin Cancer” feature, we hear about the advantages of 40-GEP testingWhy Are Dermatologists Not Writing Biologics?
https://practicaldermatology.com/topics/practice-management/why-are-dermatologists-inoti-writing-biologics/23427/Biologics have been shown to be both safe and effective for a variety of indications, so why don’t more dermatologists prescribe them?Everything Old Is New Again: Re-assessing IPL
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/everything-old-is-new-again-re-assessing-ipl/23013/Long-term IPL use may turn the tables on aging skin.Impetigo: An Unconventional Case Report
https://practicaldermatology.com/topics/rare-disease/impetigo-an-unconventional-case-report/26246/Mauri Hart, a medical student at the Oklahoma State University College of Osteopathic Medicine, takes a look at a unique case study, and tests the reader's knowledge of impetigo.